| abstract |
The present invention relates to novel compounds of the general formula (I), the use of these compounds as medicaments, pharmaceutical compositions comprising these compounds, and methods of treatment with these compounds and compositions. These compounds are useful in treating and / or preventing conditions mediated by nuclear receptors, particularly peroxisome proliferator-activated receptors (PPAR). The compounds exert their effect by modulating the PPAR response in a partial agonist manner. |